Subsequent research has revealed that downregulating PRMT1 intensifies hepatic steatosis in mice, whereas overexpressing wild‐type PRMT1 alleviates liver fat accumulation caused by a HFD. The gene discussed is PRMT1; the disease is fatty liver disease.